These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3062079

  • 21. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K, Angelin B, Leijd B, Einarsson K.
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [Abstract] [Full Text] [Related]

  • 22. Gallstones: current concepts of pathogenesis and medical dissolution.
    Shaffer EA.
    Can J Surg; 1980 Nov; 23(6):517-32, 557. PubMed ID: 7004612
    [Abstract] [Full Text] [Related]

  • 23. [Results of the treatment with biliary dissolvents].
    Dhumeaux D.
    Rev Prat; 1992 Jun 15; 42(12):1478-81. PubMed ID: 1411169
    [Abstract] [Full Text] [Related]

  • 24. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS, Salen G, Colalillo A, Graber D, Verga D, Speck J, Shefer S.
    Ann Intern Med; 1982 Sep 15; 97(3):351-6. PubMed ID: 7051912
    [Abstract] [Full Text] [Related]

  • 25. Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.
    Ros E, Navarro S, Fernández I, Reixach M, Ribó JM, Rodés J.
    Gastroenterology; 1986 Sep 15; 91(3):703-12. PubMed ID: 3732768
    [Abstract] [Full Text] [Related]

  • 26. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1984 Feb 15; 27(2):95-131. PubMed ID: 6365507
    [Abstract] [Full Text] [Related]

  • 27. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S.
    Ann Chir; 1989 Feb 15; 43(6):417-9. PubMed ID: 2817740
    [Abstract] [Full Text] [Related]

  • 28. [Prevention of recurrence after successful gallstone dissolution].
    Leiss O, von Bergmann K.
    Z Gastroenterol; 1991 Jun 15; 29(6):301-5. PubMed ID: 1926965
    [Abstract] [Full Text] [Related]

  • 29. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J, Kratzer W, Janowitz P, Mason R, Wechsler JG.
    Am J Gastroenterol; 1995 Nov 15; 90(11):1942-8. PubMed ID: 7484996
    [Abstract] [Full Text] [Related]

  • 30. Routine determination of biliary lipid composition with the entero-test.
    Muraca M, Pazzi P, Vilei MT, Miconi L, Granato A, Cianci V, Sighinolfi D, Alvisi A, Gerunda G, Maffei Faccioli A.
    Ann Chir; 1994 Nov 15; 48(2):197-200. PubMed ID: 8192414
    [Abstract] [Full Text] [Related]

  • 31. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K, Epple-Gutsfeld M, Leiss O.
    Gastroenterology; 1984 Jul 15; 87(1):136-43. PubMed ID: 6724256
    [Abstract] [Full Text] [Related]

  • 32. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K.
    Acta Chir Scand Suppl; 1985 Jul 15; 528():1-38. PubMed ID: 3866449
    [No Abstract] [Full Text] [Related]

  • 33. Types and chemical composition of intrahepatic stones.
    Suzuki N, Takahashi W, Sato T.
    Prog Clin Biol Res; 1984 Jul 15; 152():71-80. PubMed ID: 6473392
    [Abstract] [Full Text] [Related]

  • 34. Ursodeoxycholic acid for chronic liver diseases.
    Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M.
    J Clin Gastroenterol; 1988 Jul 15; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [Abstract] [Full Text] [Related]

  • 35. Pathogenesis of cholesterol gallstones.
    Hofmann AF.
    J Clin Gastroenterol; 1988 Jul 15; 10 Suppl 2():S1-11. PubMed ID: 3062078
    [Abstract] [Full Text] [Related]

  • 36. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
    Shoda J, He BF, Tanaka N, Matsuzaki Y, Osuga T, Yamamori S, Miyazaki H, Sjövall J.
    Hepatology; 1995 May 15; 21(5):1291-302. PubMed ID: 7737634
    [Abstract] [Full Text] [Related]

  • 37. [Cholelitholysis--gallbladder sediments and pigment stones].
    Wolpers C, Wosiewitz U.
    Leber Magen Darm; 1985 Mar 15; 15(2):64-70. PubMed ID: 3990499
    [Abstract] [Full Text] [Related]

  • 38. Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones.
    Tint GS, Dyrszka H, Sanghavi B, Patel G, Patel S, Shefer S, Salen G.
    Gastroenterology; 1992 Jun 15; 102(6):2042-9. PubMed ID: 1587422
    [Abstract] [Full Text] [Related]

  • 39. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S.
    Eur J Surg; 1996 Jun 15; 162(6):463-9. PubMed ID: 8817223
    [Abstract] [Full Text] [Related]

  • 40. Dissolution of human cholesterol gallstones in stimulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. An in vitro study of dissolution rates and mechanisms.
    Park YH, Igimi H, Carey MC.
    Gastroenterology; 1984 Jul 15; 87(1):150-8. PubMed ID: 6724258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.